Madrigal Pharmaceuticals, Inc. (MDGL)
435.01
-1.86
(-0.43%)
USD |
NASDAQ |
Feb 20, 16:00
435.20
+0.19
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals Research and Development Expense (Quarterly) : 115.88M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 3.206B |
| Eli Lilly & Co. | 3.802B |
| Insmed, Inc. | 254.91M |
| Johnson & Johnson | 4.268B |
| Crinetics Pharmaceuticals, Inc. | 89.45M |